… However, the mechanism(s) by which this coregulator impacts ER signaling and
pharmacology in breast cancer remains unclear. Another interesting coregulator is RTA-1/Fox2, a …

… mechanisms. This review describes each of these drugs and the varying effects each of them
have upon breast cancer cells… The mechanisms by which these agents inhibit breast cancer …

… that is used to treat breast cancer, especially HER-positive breast cancer; however, the …
, and pharmacological and molecular mechanism of its action against cancer remain unclear. …

… Therefore, the network pharmacology method is used for … -positive breast cancer and its
pharmacological mechanism from … mechanism of the development of ER-positive breast cancer …

… in breast cancer cells as well as the potential for pharmacological modulators of specific Ca
2… These include identifying the mechanisms responsible for altered expression and the most …

… exerted a promising preventive effect on breast cancer by … understand the mechanism of the
anti-breast cancer activity … the possible mechanisms involved in the anti-breast cancer effect …

… The aim of the present paper is to focus on the mechanism of action of both estrogens and
… analysed in terms of current and potential clinical applications to breast cancer treatment. …

… the molecular mechanism of the action of XCHT in BC using network pharmacology and …
in the clinic, but its mechanism in the treatment of breast adenocarcinoma has not been reported…

… The complex molecular mechanisms behind the survival of BCSCs and pharmacological
targets … Breast cancer is the most common type of cancer in women and is the second leading …

… Invasive breast cancer is classified into three therapeutic clinical subtypes: HR-positive, …
breast cancer and intra-tumoral heterogeneity [1]. In addition to this heterogeneity, breast cancer …